about
Micro- and Macrostructured PLGA/Gelatin Scaffolds Promote Early Cardiogenic Commitment of Human Mesenchymal Stem Cells In Vitro.Molecularly imprinted polymeric micro- and nano-particles for the targeted delivery of active molecules.A poly(ether-ester) copolymer for the preparation of nanocarriers with improved degradation and drug delivery kinetics.Polymer Nanoparticles as Smart Carriers for the Enhanced Release of Therapeutic Agents to the CNS.Novel biodegradable nanocarriers for enhanced drug delivery.Molecularly Imprinted Biodegradable Nanoparticles.Recent advances in preclinical studies and potential applications of dendrimers as drug carriers in the Central Nervous System.Biomimetic and bioinspired nanoparticles for targeted drug delivery.Surface functionalisation regulates polyamidoamine dendrimer toxicity on blood-brain barrier cells and the modulation of key inflammatory receptors on microglia.Experimental and computational study of mechanical and transport properties of a polymer coating for drug-eluting stents.Macromolecular composition and drug-loading effect on the delivery of paclitaxel and folic acid from acrylic matrices.Combined drug release from biodegradable bilayer coating for endovascular stents.Novel biodegradable, biomimetic and functionalised polymer scaffolds to prevent expansion of post-infarct left ventricular remodelling.Acrylic copolymers as candidates for drug-eluting coating of vascular stents.The effect of bioartificial constructs that mimic myocardial structure and biomechanical properties on stem cell commitment towards cardiac lineage.Ring-opening copolymerization thermodynamics and kinetics of γ-valerolactone/ϵ-caprolactone.Chemical synthesis of a biodegradable PEGylated copolymer from ε-caprolactone and γ-valerolactone: evaluation of reaction and functional propertiesChitosan-Based Macromolecular Biomaterials for the Regeneration of Chondroskeletal and Nerve TissueTargeted drug delivery across biological barriers using polymer nanoparticlesLong-term EVA degradation simulation: Climatic zones comparison and possible revision of accelerated testsA reaction-diffusion formulation to simulate EVA polymer degradation in environmental and accelerated ageing conditionsAdhesion properties of poly(methylmethacrylate‐ co ‐ n ‐butylmethacrylate) copolymers in stent coatingsMathematical Modeling and Experimental Study of Water Diffusion and Swelling in Polymer FilmsTime- and Solvent-Dependent Self-Assembly of Photochromic CrystallitesPolymeric PEGylated nanoparticles as drug carriers: How preparation and loading procedures influence functional propertiesOn the effect of macromolecular composition and drug loading on thermal and tensile mechanical properties of methyl methacrylate and butyl methacrylate copolymersIn vitro haematic proteins adsorption and cytocompatibility study on acrylic copolymer to realise coatings for drug-eluting stentsPolymeric nanocarriers for controlled and enhanced delivery of therapeutic agents to the CNSComputational models for the in silico analysis of drug delivery from drug-eluting stentsBIODEGRADABLE BIOARTIFICIAL MATERIALS MADE BY CHITOSAN AND POLY(VINYL ALCOHOL) PART III: MATERIALS TOUGHENED BY MEANS OF A DEHYDROTHERMAL TREATMENTNON CONVENTIONAL SURFACE FUNCTIONALIZATION OF POROUS POLY-ε-CAPROLACTONE SCAFFOLDS USING BIOACTIVE MOLECULARLY IMPRINTED NANOSPHERESDifferent composition poly(methyl methacrylate-co-butyl methacrylate) copolymers through seeded semi-batch emulsion polymerizationSynthesis and characterization of copolymers of methylmethacrylate and 2-hydroxyethyl methacrylate for the aqueous solubilization of PaclitaxelBioartificial chitosan-poly(vinyl alcohol) blends as biomaterials
P50
Q37378396-01D7B05A-03AC-49A7-A425-A3DF2A648298Q38357073-145F2832-F8A2-4CBB-8ACB-F006D38B0503Q38813043-3F94398E-6895-4D62-9B45-66707A84EE41Q38995487-BD8229EC-F312-471F-8772-7FFA8FFF3282Q39005331-2199ECB3-696C-4DF8-82FB-373F0031ADB3Q39029646-2F99581D-00BB-48AC-A65E-6B734401BBCDQ39178909-294AD0F9-656F-4219-983F-CDBD23F4C8C5Q39210548-C9460098-152E-4B47-8D71-F649C8E2E81FQ39214441-779B7408-065A-4D65-9422-E51F8F3B7088Q40273207-A285E5D1-21BF-4BD0-9A65-0377078C41AAQ43053844-5192750A-0291-48FD-BC62-C9F577A772DCQ43179050-97A94AA5-B261-437B-AFDB-72F9D8441374Q45381548-2EDF61F9-ECA5-43C6-B77C-009B9CECE04EQ46228970-272FA326-0141-4DA4-A078-BD048E99F7B2Q47971874-39DECBB2-1D88-4D37-A98F-6EEA22DEA9B4Q55496664-9E4917BA-4E12-4F25-AE1E-5FC5CC6CC272Q56681327-173050AE-E10F-4867-8C4B-860FFB9E2D6AQ58655848-5D67C7DA-67DC-4DB0-955E-BF491344E805Q61988403-D317C584-1ACD-485C-887A-01D4FC2CE4BAQ64012109-CC5823AE-17E2-4DCC-BEFB-6B8D7593951AQ64012122-717EEB79-0B31-4288-84E3-E86D9C5578BFQ64016408-8ECA1526-52FA-42EF-BC34-D8E423CBBD0BQ64016409-8D7B05CA-77B1-4AF9-A71F-187052FE1622Q64016410-E1B289B1-0BBD-49F6-801E-AC95134EA610Q64016411-2A773470-8B70-4702-922A-4FFDC50D0B8DQ64016412-D6A9FB7F-D858-4B7E-B517-0614FD9B6C15Q64016415-2DF41C1B-214E-48FB-AC6F-02E6A55B5DD0Q64016416-B7A788EB-5D1C-4357-B614-B8C2F970013CQ64016418-C1198226-09CB-4986-B7F0-929FD2022EB8Q64016419-5CD02C7A-EE69-4494-8A4C-02F7961DC549Q64016421-CBD94EA9-5734-476F-A357-99A896FF5AE6Q64016422-C2C95B57-19BE-433E-BEA0-DA0875BAA17AQ64016423-0ABDAE4E-499A-4E35-8E42-2385FDCB6A1DQ64016424-C20E17A4-75FD-42C3-91DA-E5CBA6615136
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Mariacristina Gagliardi
@ast
Mariacristina Gagliardi
@en
Mariacristina Gagliardi
@es
Mariacristina Gagliardi
@nl
type
label
Mariacristina Gagliardi
@ast
Mariacristina Gagliardi
@en
Mariacristina Gagliardi
@es
Mariacristina Gagliardi
@nl
altLabel
M. Gagliardi
@nl
prefLabel
Mariacristina Gagliardi
@ast
Mariacristina Gagliardi
@en
Mariacristina Gagliardi
@es
Mariacristina Gagliardi
@nl
P106
P1153
23995257200
P21
P31
P496
0000-0002-5860-3141